Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients.
Sarcoidosis vasculitis and diffuse lung diseases · 29.06.2023 · 40 (2) · e2023019-e2023019
DOI: 10.36141/svdld.v40i2.12900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sarcoidosis vasculitis and diffuse lung diseases, erschienen am 29.06.2023. Verfasst von Silvia Bocci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neurology and Clinical Neurophysiology, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, 53100 Siena, Italy;. …. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Krebs von den Lungen-6 (KL-6) is a high molecular weight (MW) glycoprotein mainly secreted by type II pneumocytes because of lung damage or during regeneration. Neurosarcoidosis (NS), where sarcoid granulomas involve the nervous system, occurs in 5-20% of patients with sarcoidosis. No data is currently available on KL-6 in serum or CSF of NS patients. The present study compared KL-6 concentrations in serum and CSF of NS patients versus others with neurodegenerative (ND) or chronic inflammatory demyelinating (DM) diseases. MATERIALS AND METHODS: Nine NS patients (mean age 46.2 years, range 16-61 years, M/F 5/4), nine patients with a chronic neurodegenerative disease (mean age 53.1 years, range 37-65 years, M/F 5/4) and nine patients with a chronic demyelinating disease (mean age 46.3 years, range 18-65 years, M/F 5/4) were retrospectively enrolled. RESULTS: Measurable CSF concentrations of KL-6 were detected in 7/9 NS patients but in no ND or DM patients. No significant differences in CSF concentrations of ACE were observed between the three groups (p=0.0819). In NS patients, CSF concentrations of KL-6 were directly correlated with CSF albumin index (r=0.98; p
Schlagwörter
Autor:innen und Institutionen
- Neurology and Clinical Neurophysiology, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, 53100 Siena, Italy;. silvia.bocci87@gmail.com.
- university of siena. dalessandro.miriana@gmail.com.
- Respiratory Diseases and Lung Transplant, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, 53100 Siena, Italy. laurabergantini@gmail.com.
- Unit of Neuroimaging, Diagnostic and Functional Neuroradiology, Department of Neurological and Motor Sciences, Siena University Hospital, Siena, 53100, Italy. alfonso.cerase@ao-siena.toscana.it.
- Neurology and Clinical Neurophysiology, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, 53100 Siena, Italy. monica.ulivelli@unisi.it.
- Respiratory Diseases and Lung Transplant, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, 53100 Siena, Italy. paola.rottoli@unisi.it.
Zitieren
APA
Bocci, S., D'Alessandro, M., Bergantini, L., Cerase, A., Ulivelli, M., Rottoli, P., Cavallaro, D., Gangi, S., Bargagli, E., & Giannini, F. (2023). Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients. Sarcoidosis vasculitis and diffuse lung diseases, 40(2), e2023019-e2023019. https://doi.org/10.36141/svdld.v40i2.12900
Vancouver
Bocci S, D'Alessandro M, Bergantini L, Cerase A, Ulivelli M, Rottoli P, et al. Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients. Sarcoidosis vasculitis and diffuse lung diseases. 2023;40(2):e2023019-e2023019. doi:10.36141/svdld.v40i2.12900
BibTeX
@article{Bocci2023,
author = {Bocci, Silvia and D'Alessandro, Miriana and Bergantini, Laura and Cerase, Alfonso and Ulivelli, Monica and Rottoli, Paola and Cavallaro, Dalila and Gangi, Sara and Bargagli, Elena and Giannini, Fabio},
title = {Krebs von den Lungen-6 (KL-6) in cerebrospinal fluid from neurosarcoidosis patients},
journal = {Sarcoidosis vasculitis and diffuse lung diseases},
year = {2023},
volume = {40},
number = {2},
pages = {e2023019--e2023019},
doi = {10.36141/svdld.v40i2.12900}
}
EUVIMED